Early Circulating Tumor DNA Dynamics Predict Fruquintinib Efficacy in Refractory Metastatic Colorectal Cancer Before Imaging - Quiz - MDSpire

Early Circulating Tumor DNA Dynamics Predict Fruquintinib Efficacy in Refractory Metastatic Colorectal Cancer Before Imaging

  • By

  • Hou, Hebin

  • Liu, Pingping

  • Dong, Xiaohuan

  • Gai, Wei

  • Jiang, Peng

  • Yang, Fan

  • Hao, Chongli

  • May 20, 2026

  • 0 min

Share

Original Source(s)

Early Circulating Tumor DNA Dynamics Predict Fruquintinib Efficacy in Refractory Metastatic Colorectal Cancer Before Imaging

  • by Hou, Hebin , Liu, Pingping , Dong, Xiaohuan , Gai, Wei , Jiang, Peng , Yang, Fan , Hao, Chongli

  • May 20, 2026

Related Content

Prognostic model for three-year postoperative local recurrence in cutaneous squamous cell carcinoma: a Chinese multicenter cohort study

Editorial: Understanding oral health challenges in pediatric and adult cancer care

Predicting CAR-T outcomes in R/R DLBCL: a multicenter real-world study of a 5-index model